GD2-positive Solid Tumors
1 clinical trials · Condition
◉ Watch GD2-positive Solid Tumors
| Record | Firm | Date |
|---|---|---|
| Anti-GD2 CAR T Cells in Pediatric Patients Affected by High Risk and/or Relapsed/Refractory Neuroblastoma or Other GD2-positive Solid Tumors (NCT03373097) | Bambino Gesù Hospital and Research Institute | 2018-01-05 |
Track GD2-positive Solid Tumors automatically
Every clearance here is in the API, with alerts when new ones post.